Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules - PubMed (original) (raw)

Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules

E Varecková et al. Arch Virol. 1993.

Abstract

Haemagglutinin (HA) was detected on the surface of influenza virus infected cell with monoclonal antibodies (MAbs) against both HA glycopolypeptides, HA1 and HA2, however, the reactivity of HA2-specific MAbs was remarkably lower as compared with HA1-specific MAbs. Quantitative analysis with two MAbs, IB8 (anti-HA1) and IIF4 (anti-HA2) respectively, revealed that HA2 epitope was reachable for antibody only in minor subpopulation of the HA representing approximately 7% of all molecules (spikes). The basis of the HA heterogeneity is discussed.

PubMed Disclaimer

Similar articles

• Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
  Russ G, Poláková K, Kostolanský F, Styk B, Vancíková M. Russ G, et al. Acta Virol. 1987 Sep;31(5):374-86. Acta Virol. 1987. PMID: 2891276
• Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.
  Kostolansky F, Russ G, Mucha V, Styk B. Kostolansky F, et al. Arch Virol. 1988;101(1-2):13-24. doi: 10.1007/BF01314648. Arch Virol. 1988. PMID: 2458086
• Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits.
  Sánchez-Fauquier A, Villanueva N, Melero JA. Sánchez-Fauquier A, et al. Arch Virol. 1987;97(3-4):251-65. doi: 10.1007/BF01314425. Arch Virol. 1987. PMID: 3322235
• The influenza virus-infected host cell, a target for the immune response.
  Becht H, Weiss HP. Becht H, et al. Behring Inst Mitt. 1991 Jul;(89):1-11. Behring Inst Mitt. 1991. PMID: 1930089 Review.

Cited by

• Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic.
  Ninyio NN, Ho KL, Omar AR, Tan WS, Iqbal M, Mariatulqabtiah AR. Ninyio NN, et al. Vaccines (Basel). 2020 Nov 19;8(4):694. doi: 10.3390/vaccines8040694. Vaccines (Basel). 2020. PMID: 33227887 Free PMC article. Review.
• Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.
  Vogel OA, Manicassamy B. Vogel OA, et al. Front Microbiol. 2020 Feb 7;11:135. doi: 10.3389/fmicb.2020.00135. eCollection 2020. Front Microbiol. 2020. PMID: 32117155 Free PMC article. Review.
• Influenza Hemagglutinin and Neuraminidase: Yin⁻Yang Proteins Coevolving to Thwart Immunity.
  Kosik I, Yewdell JW. Kosik I, et al. Viruses. 2019 Apr 16;11(4):346. doi: 10.3390/v11040346. Viruses. 2019. PMID: 31014029 Free PMC article. Review.
• Development of a Universal Influenza Vaccine.
  Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.
• A Unique Multibasic Proteolytic Cleavage Site and Three Mutations in the HA2 Domain Confer High Virulence of H7N1 Avian Influenza Virus in Chickens.
  Abdelwhab el-SM, Veits J, Tauscher K, Ziller M, Teifke JP, Stech J, Mettenleiter TC. Abdelwhab el-SM, et al. J Virol. 2015 Oct 21;90(1):400-11. doi: 10.1128/JVI.02082-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26491158 Free PMC article.

References

1. 1. Acta Virol. 1979 Jan;23(1):1-8 - PubMed
2. 1. J Cell Biol. 1989 Jun;108(6):2117-26 - PubMed
3. 1. Acta Virol. 1987 Sep;31(5):374-86 - PubMed
4. 1. Virology. 1990 Dec;179(2):768-76 - PubMed
5. 1. Virology. 1983 Apr 15;126(1):106-16 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal